HSU JASON purchased 2.8% of their position (23.10K shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $51.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/26/2024ACC: 0001493152-24-033900
+23.10K
Net shares
Net buyer
$51.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
23.10K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$2.23
Trade value
$33.39K
% of position
1.8%
8/21/2024
822.20K→837.20K
Common Stock
Direct
Shares
+8.10K
Price / share
$2.25
Trade value
$18.23K
% of position
1.0%
8/22/2024
837.20K→845.30K
Total
Net shares
+23.10K
Net value
$51.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2024 | P · Purchase | +15K | $2.23 | $33.39K | 1.8% | 822.20K | 837.20K |
| Common Stock Direct | 8/22/2024 | P · Purchase | +8.10K | $2.25 | $18.23K | 1.0% | 837.20K | 845.30K |
| Total | +23.10K | $51.62K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned50K
Common Stock
IndirectShares owned3.92M
Total
3.97M indirect3.97M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 50K | Indirect |
| Common Stock | 3.92M | Indirect |
| Total | 3.97M | 3.97M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported